Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ.

Int J Neuropsychopharmacol. 2014 Feb;17(2):331-6. doi: 10.1017/S1461145713001119. Epub 2013 Oct 8.

PMID:
24103211
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct 1;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

PMID:
23982301
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.

Duncan WC, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, Yuan P, Brutsche N, Manji HK, Tononi G, Zarate CA.

Int J Neuropsychopharmacol. 2013 Mar;16(2):301-11. doi: 10.1017/S1461145712000545. Epub 2012 Jun 7.

PMID:
22676966
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

Machado-Vieira R, Yuan P, Brutsche N, DiazGranados N, Luckenbaugh D, Manji HK, Zarate CA Jr.

J Clin Psychiatry. 2009 Dec;70(12):1662-6. doi: 10.4088/JCP.08m04659. Epub 2009 Sep 8.

PMID:
19744406
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.

Palm U, Fintescu Z, Obermeier M, Schiller C, Reisinger E, Keeser D, Pogarell O, Bondy B, Zill P, Padberg F.

J Affect Disord. 2013 Sep 5;150(2):659-63. doi: 10.1016/j.jad.2013.03.015. Epub 2013 May 7.

PMID:
23664268
[PubMed - indexed for MEDLINE]
6.

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016. Epub 2013 Oct 2.

PMID:
24096053
[PubMed - indexed for MEDLINE]
7.

Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.

Ricken R, Adli M, Lange C, Krusche E, Stamm TJ, Gaus S, Koehler S, Nase S, Bschor T, Richter C, Steinacher B, Heinz A, Rapp MA, Borgwardt S, Hellweg R, Lang UE.

J Clin Psychopharmacol. 2013 Dec;33(6):806-9. doi: 10.1097/JCP.0b013e3182a412b8.

PMID:
24018547
[PubMed - indexed for MEDLINE]
8.

Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?

Rybakowski JK, Permoda-Osip A, Skibinska M, Adamski R, Bartkowska-Sniatkowska A.

Hum Psychopharmacol. 2013 Jan;28(1):87-90. doi: 10.1002/hup.2271. Epub 2012 Nov 5.

PMID:
23124710
[PubMed - indexed for MEDLINE]
9.

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV.

Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.

PMID:
22840761
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study.

Kurita M, Nishino S, Kato M, Numata Y, Sato T.

PLoS One. 2012;7(6):e39212. doi: 10.1371/journal.pone.0039212. Epub 2012 Jun 27.

PMID:
22761741
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.

Ibrahim L, Diazgranados N, Franco-Chaves J, Brutsche N, Henter ID, Kronstein P, Moaddel R, Wainer I, Luckenbaugh DA, Manji HK, Zarate CA Jr.

Neuropsychopharmacology. 2012 May;37(6):1526-33. doi: 10.1038/npp.2011.338. Epub 2012 Feb 1.

PMID:
22298121
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Lotrich FE, Albusaysi S, Ferrell RE.

Neuropsychopharmacology. 2013 May;38(6):985-95. doi: 10.1038/npp.2012.263. Epub 2012 Dec 18.

PMID:
23303061
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder.

Gustafsson G, Lira CM, Johansson J, Wisén A, Wohlfart B, Ekman R, Westrin A.

Psychiatry Res. 2009 Oct 30;169(3):244-8. doi: 10.1016/j.psychres.2008.06.030. Epub 2009 Sep 3.

PMID:
19729204
[PubMed - indexed for MEDLINE]
14.

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.

Yasui-Furukori N, Tsuchimine S, Nakagami T, Fujii A, Sato Y, Tomita T, Yoshizawa K, Inoue Y, Kaneko S.

Hum Psychopharmacol. 2011 Apr;26(3):194-200. doi: 10.1002/hup.1192.

PMID:
21638327
[PubMed - indexed for MEDLINE]
15.

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.

Ibrahim L, Diaz Granados N, Jolkovsky L, Brutsche N, Luckenbaugh DA, Herring WJ, Potter WZ, Zarate CA Jr.

J Clin Psychopharmacol. 2012 Aug;32(4):551-7. doi: 10.1097/JCP.0b013e31825d70d6.

PMID:
22722512
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, Zarate CA Jr.

Biol Psychiatry. 2012 Oct 1;72(7):555-61. doi: 10.1016/j.biopsych.2012.03.029. Epub 2012 Apr 21.

PMID:
22521148
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS.

JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62.

PMID:
24740528
[PubMed - indexed for MEDLINE]
18.

Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.

Luckenbaugh DA, Ibrahim L, Brutsche N, Franco-Chaves J, Mathews D, Marquardt CA, Cassarly C, Zarate CA Jr.

Bipolar Disord. 2012 Dec;14(8):880-7. doi: 10.1111/bdi.12003. Epub 2012 Sep 14.

PMID:
22978511
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM.

Psychiatry Res. 2002 Mar 15;109(2):143-8.

PMID:
11927139
[PubMed - indexed for MEDLINE]
20.

Ketamine, sleep, and depression: current status and new questions.

Duncan WC Jr, Zarate CA Jr.

Curr Psychiatry Rep. 2013 Sep;15(9):394. doi: 10.1007/s11920-013-0394-z. Review.

PMID:
23949569
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk